Insilica
Insilica accelerates the safety lifecycle from lead optimization to filing. Its platform, ToxIndex, uses agentic AI to de-risk preclinical research by screening candidates against human-relevant NAMs to identify liabilities early. Once a lead is selected, ToxIndex automates the regulatory submission process, generating expert-validated OEL and HBEL dossiers in hours, not weeks. By providing transparent, high-fidelity evidence for IND packages, Insilica reduces late-stage attrition and meets modern FDA standards for non-animal safety data.
